Proposed Regulatory Changes
Proposed Licensing and Practice Regulations:
KAR 68-1-3a, 68-2-20, 68-7-12a, 68-7-15, 68-7-20, and 68-11-2
Notice of Public Hearing
Economic Impact Statement
Final Approved Naloxone Regulation:
Approved Permanent KAR 68-7-23
The following bills from the 2017 legislative session have been signed by the Governor and enrolled:
Sen Sub for HB 2055 - Pharmacy Practice Act Amendments (now effective)
HB 2030 - Immunization Authority for Pharmacists (effective July 1, 2017)
HB 2217 - Emergency Opioid Antagonists (effective July 1, 2017)
H Sub for SB 51 - Controlled Substance Act Update and Emergency Scheduling Authority (now effective)
quoted from http://pharmacy.ks.gov/statutes-regs/proposed-changes
KAR 68-1-3a, 68-2-20, 68-7-12a, 68-7-15, 68-7-20, and 68-11-2
Notice of Public Hearing
Economic Impact Statement
Final Approved Naloxone Regulation:
Approved Permanent KAR 68-7-23
The following bills from the 2017 legislative session have been signed by the Governor and enrolled:
Sen Sub for HB 2055 - Pharmacy Practice Act Amendments (now effective)
HB 2030 - Immunization Authority for Pharmacists (effective July 1, 2017)
HB 2217 - Emergency Opioid Antagonists (effective July 1, 2017)
H Sub for SB 51 - Controlled Substance Act Update and Emergency Scheduling Authority (now effective)
quoted from http://pharmacy.ks.gov/statutes-regs/proposed-changes
No comments:
Post a Comment